• Norgine Ventures is a leading provider of financing for innovative healthcare companies

  • Norgine Ventures is a leading provider of financing for innovative healthcare companies

Innovative healthcare financing

Innovative healthcare financing

Norgine Ventures was started in 2012 to diversify Norgine’s activities and foster innovation in the healthcare sector. Norgine Ventures provides debt and debt-like financing to innovative, fast-growing companies in the fields of healthcare and life sciences, in Europe and the US.

Norgine Ventures is backed by Norgine, a fully integrated, private, European healthcare company with over 115 years of experience in the pharma space. Norgine Ventures has full access to Norgine’s technical capabilities for evaluating investment opportunities, although the business is aimed at achieving a financial return rather than funding opportunities of strategic interest to Norgine.

To date, Norgine Ventures has invested in a number of businesses, including specialty pharma, diagnostic, digital health and medical device companies, at various stages of their life cycle, both in Europe and in the US.

Norgine Ventures were unbelievable. We were a very young company with not much track record, but with a vision. Norgine Ventures believed in us and provided much needed financing at the right time on extremely good financial terms… Working with the team was fantastic… We exited extremely well a few years later and if it was not for Norgine Ventures we would not have achieved what we did.”

CEO of a European pharmaceutical company

Norgine Ventures has committed funds in excess of €170m to healthcare companies in Europe and in the US.